An official website of the United States government
Table 3.5. Number and rates* of newly reported cases† of chronic hepatitis C virus infection, by state or jurisdiction — United States, 2019
* Rates per 100,000 population.
† Reported cases that met the classification criteria for a confirmed case. For case definition, see https://ndc.services.cdc.gov/conditions/hepatitis-c-chronic/.
—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable. The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.
In the United States, chronic hepatitis C is one of the leading causes of cirrhosis, a major cause of liver cancer. This table displays the number and rates of newly reported chronic hepatitis C cases during 2019, by state or jurisdiction. Because health departments might not have adequate resources for investigating all cases reported in their jurisdiction, certain cases of acute hepatitis C might be misclassified as chronic hepatitis C if health departments are not able to identify symptoms or laboratory abnormalities necessary for classifying a case as acute. Of note, cases of newly reported chronic hepatitis C do not represent all prevalent hepatitis C infections, which cannot be captured in the National Notifiable Diseases Surveillance System.
Of the 123,312 newly reported cases of chronic hepatitis C during 2019, approximately one-third were from 4 states (Florida, Pennsylvania, Ohio, and Tennessee). The highest rate of newly reported cases of chronic hepatitis C was in West Virginia (201.0 cases per 100,000 population) followed by Alaska, Tennessee, and New Mexico where rates were >100 cases per 100,000 population.
- Figure 3.1. Number of reported acute hepatitis C virus infection cases and estimated infections — United States, 2012–2019
- Figure 3.2. Rates of reported acute hepatitis C virus infections, by state — United States, 2018–2019
- Figure 3.3. Rates of reported acute hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Figure 3.4. Rates of reported acute hepatitis C virus infection, by age group — United States, 2004–2019
- Figure 3.5. Rates of reported acute hepatitis C virus infection, by sex — United States, 2004–2019
- Figure 3.6. Rates of reported acute hepatitis C virus infection, by race/ethnicity — United States, 2004–2019
- Figure 3.7. Availability of information regarding risk behaviors or exposures associated with reported cases of acute hepatitis C virus infection — United States, 2019
- Figure 3.8. Number of newly reported chronic hepatitis C virus infection cases, by sex and age — United States, 2019
- Figure 3.9. Rates of death with hepatitis C virus infection listed as a cause of death among residents, by jurisdiction — United States, 2019
- Table 3.1. Number and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2015–2019
- Table 3.2. Number and rates of reported cases of acute hepatitis C, by demographic characteristics — United States 2015–2019
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C virus infection — United States, 2019
- Table 3.4. Number of newly reported cases of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Table 3.5. Number and rates of newly reported cases of chronic hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Table 3.6. Number and rates of newly reported cases of chronic hepatitis C virus infection, by demographic characteristics — United States, 2019
- Table 3.7. Number and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2015–2019
- Table 3.8. Number and rates of deaths with hepatitis C virus infection listed as a cause of death among residents, by demographic characteristics — United States, 2015–2019